【新股首日 | 银诺医药-B(02591.HK)首挂上市 早盘高开285.44% 核心产品依苏帕格鲁肽α今年1月获批上市】智通财经APP获悉，银诺医药-B(02591.HK)首挂上市，公告显示，每股定价18.68港元，共发行3655.64万股股份，每手200股，所得款项净额约6.347亿港元。截至发稿，涨285.44%，报72港元，成交额3亿港元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.